JAGUAR HEALTH INC (JAGX) Stock Analyst Ratings
USA - NASDAQ:JAGX - US47010C8881 - Common Stock
1.3675 USD
-0.29 (-17.62%)
ChartMill assigns a Buy % Consensus number of 86% to JAGX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.32. This target is 1093.42% above the current price.
JAGX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about JAGX.
In the previous month the buy percentage consensus was at a similar level.
JAGX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | First Berlin | Initiate | Buy |
| 2021-07-07 | Cantor Fitzgerald | Initiate | Overweight |
JAGUAR HEALTH INC / JAGX FAQ
What is the price target for JAGX stock?
7 analysts have analysed JAGX and the average price target is 16.32 USD. This implies a price increase of 1093.42% is expected in the next year compared to the current price of 1.3675.
Can you provide the consensus rating for JAGUAR HEALTH INC stock?
The consensus rating for JAGUAR HEALTH INC (JAGX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.